Physical mapping and genomic structure of the Lowe syndrome gene OCRL1

被引:72
作者
Nussbaum, RL
Orrison, BM
Janne, PA
Charnas, L
Chinault, AC
机构
[1] UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104
[2] UNIV PENN,SCH MED,MOL BIOL GRAD GRP,PHILADELPHIA,PA 19104
[3] NICHHD,HEREDITARY DISORDERS BRANCH,BETHESDA,MD
[4] BAYLOR COLL MED,DEPT MOL GENET,HOUSTON,TX 77030
关键词
D O I
10.1007/s004390050329
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The oculocerebrorenal syndrome of Lowe (OCRL; McKusick 309000) is a rare X-linked disorder characterized by mental retardation, congenital cataracts, and Fanconi syndrome of the proximal renal tubules. We have carried out physical mapping of the OCRL1 gene and determined that it contains 24 exons occupying 58 kb. The gene, located in Xq25-26, is transcribed in a centromeric to telomeric direction. Primers have been developed that allow all coding exons and their intron/exon boundaries to be amplified from genomic DNA for mutation detection. Two tetranucleotide tandem repeat polymorphisms were characterized that immediately flank the OCRL1 gene and, together, are informative in over 90% of females. Variable splicing was seen in the OCRL1 transcript, involving a small 24-bp exon. These results should prove useful to medical and molecular geneticists studying mutations and providing DNA diagnostic services to families dealing with Lowe syndrome as well as to cell biologists interested in structure-function relationships for the OCRL1 protein.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 9 条
[1]   THE LOWE OCULOCEREBRORENAL SYNDROME GENE ENCODES A PROTEIN HIGHLY HOMOLOGOUS TO INOSITOL POLYPHOSPHATE-5-PHOSPHATASE [J].
ATTREE, O ;
OLIVOS, IM ;
OKABE, I ;
BAILEY, LC ;
NELSON, DL ;
LEWIS, RA ;
MCINNES, RR ;
NUSSBAUM, RL .
NATURE, 1992, 358 (6383) :239-242
[2]   CPG ISLANDS AS GENE MARKERS IN THE VERTEBRATE NUCLEUS [J].
BIRD, AP .
TRENDS IN GENETICS, 1987, 3 (12) :342-347
[3]  
CHARNAS LR, 1994, METABOLIC BASIS INHE
[4]  
LEAHEY AM, 1993, HUM MOL GENET, V4, P461
[5]  
OLIVOSGLANDER IM, 1995, AM J HUM GENET, V57, P817
[6]   GENETIC AND PHYSICAL MAPPING OF XQ24-Q26 MARKERS FLANKING THE LOWE OCULOCEREBRORENAL SYNDROME [J].
REILLY, DS ;
LEWIS, RA ;
NUSSBAUM, RL .
GENOMICS, 1990, 8 (01) :62-70
[7]  
Sambrook J., 2002, MOL CLONING LAB MANU
[8]   LOWE-SYNDROME, A DEFICIENCY OF A PHOSPHATIDYL-INOSITOL 4,5-BISPHOSPHATE 5-PHOSPHATASE IN THE GOLGI-APPARATUS [J].
SUCHY, SF ;
OLIVOSGLANDER, IM ;
NUSSBAUM, RL .
HUMAN MOLECULAR GENETICS, 1995, 4 (12) :2245-2250
[9]   THE PROTEIN-DEFICIENT IN LOWE SYNDROME IS A PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 5-PHOSPHATASE [J].
ZHANG, XL ;
JEFFERSON, AB ;
AUETHAVEKIAT, V ;
MAJERUS, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4853-4856